A Single-Arm Prospective Investigation of the Effects of Laughter Therapy on Mood, Stress, and Self-Efficacy in People With Central Nervous System Disorders.

Study Purpose:

This is a prospective investigation of the effects of Laughter therapy (LT) on perceived stress, self-efficacy, mood and other wellness measures in people with the following neurological conditions: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury, Huntington's Disease, multiple sclerosis, Parkinson's Disease, post-stroke, spinal cord injury.

Disease:

Amyotrophic Lateral Sclerosis (ALS)

Study Type:

Interventional Trial

Study Category:

Other

Study Status:

Active, currently recruiting

Phase:

Not Applicable

Study Chair(s)/Principal Investigator(s):

Theodore R Brown, MD, MPH, Evergreen Healthcare

Clinicaltrials.gov ID (11 digit #):

NCT02750982

Neals Affiliated?

No

Coordinating Center Contact Information

Evergreen Healthcare
Carey Gonzales, CRC; Javier Nazar, RA / .(JavaScript must be enabled to view this email address) / 425-899-5385 ext 5374; 425-899-5385 ext 5370
.(JavaScript must be enabled to view this email address) Kirkland, Washington 98034 United States

Full Study Summary:

Laughter therapy (LT) has potential benefits in treating illness. It combines laughter with breathing and body exercises to stimulate laughter, both real and artificial, in a group setting. Laughter therapy may help treating illness by strengthening breathing muscles, improving mood, and providing pain and stress relief. EvergreenHealth has presented laughter therapy classes to patients with Parkinson's disease and Multiple sclerosis and other neurological conditions. The therapy will be led by a certified laughter therapist and mental health professional.

Study Sponsor:

Unknown

Participant Duration:

Estimated Enrollment:

24

Estimated Study Start Date:

06/30/2016

Estimated Study Completion Date:

12/31/2016

Posting Last Modified Date:

06/30/2016

Date Study Added to alsconsortium.org:

05/01/2016
  • Eligibility Criteria

    Gender:

    Female, Male

    Minimum Age:

    18

    Maximum Age:

    N/A

    Time since Symptom Onset:

    Time since Diagnosis:

    Can participants use Riluzole?


    Inclusion Criteria:
    -Diagnosis based on medical record review of one of the following neurological diseases: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury, Huntington's Disease, Multiple Sclerosis, Parkinson's Disease, Post-Stroke, Spinal Cord Injury.
    -Medically stable for at least 2 months.
    -Not participating in Laughter therapy for 30 days prior to screening.

    Exclusion Criteria:
    -Females who are pregnant
    -Any unstable medical condition
    -Severe cognitive deficits that would interfere with participation (e.g. unable to follow commands).
    -Severe abdominal pain, chest pain or back pain.
    -Abdominal, chest or back surgery within 90 days.
    -Psychosis or severe mental illness.
    -Untreated hernia.
    -Persistent cough.
    -Advanced hemorrhoids.
    -Epilepsy.
    -Uncontrolled Hypertension - SBP >170 or DBP >105.

  • Site Contact Information

    Evergreen Healthcare
    Kirkland, Washington 98034
    United States